4Henkler F, Koshy R. Hepatitis B virus transcrip - tional activators: mechanisms and possible role in oncoge - nesis. J Viral Hapat, 1996, 3(1): 109 - 112.
5Feitelson MA, Zhu MH, Duan LX, et al. Hepatitis BX antigen and P53 are associated in vitro and in liver tissues from patients with primary, hepatocellular carcinnma. Onto - gene, 1993, 8 (5) : 1109 - 1117.
6Takada S, Kaneniwa N, Tsuchida N, et al. Cytoplasmic retention of the P53tumor suppressor gene product is ob served in the hepatitis Bvirus Xgene- transfected cells.Oneogene, 1997, 15(16): 1895 - 1901.
7Lee SG, Rho HM. Transcriptional repression of the humon P53 gene by , hepatitis Bvirul X protein. Oncogene, 2000. 19 (3): 468 -471.
8Sohn S, Jaitovitch Groisman I, Benlimame N, et al. Retrovial expression of the hepatitis B virus X gene promotes liver cell susceptibility to carcinogen - induced site specific mutagenesis. Mutat Res, 2000, 460 ( 1 ) : 17 - 28.
9Wang XW, Forrester K, Yeh H, et al. Hepatitis B virys X proteininhibits P53 sequence - specific DNA binding, tran -scriptional activity, and association wity transcription factor ERCC3. Proc Natl Acad Sci USA, 1994, 91(6): 2230- 2234.
